12/2
09:06 am
mtva
MetaVia Inc. Announces 1-for-11 Reverse Stock Split [Yahoo! Finance]
Low
Report
MetaVia Inc. Announces 1-for-11 Reverse Stock Split [Yahoo! Finance]
12/2
08:45 am
mtva
MetaVia Inc. Announces 1-for-11 Reverse Stock Split
Medium
Report
MetaVia Inc. Announces 1-for-11 Reverse Stock Split
11/7
08:31 am
mtva
MetaVia Presents Positive New Phase 2a Data on Vanoglipel (DA-1241) in Patients with Presumed MASH at the AASLD The Liver Meeting® 2025
Medium
Report
MetaVia Presents Positive New Phase 2a Data on Vanoglipel (DA-1241) in Patients with Presumed MASH at the AASLD The Liver Meeting® 2025
11/6
08:31 am
mtva
MetaVia Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Medium
Report
MetaVia Reports Third Quarter 2025 Financial Results and Provides Corporate Update
11/4
04:25 pm
mtva
MetaVia to Present New Phase 1 and Pre-Clinical Data on DA-1726 at ObesityWeek® 2025 [Yahoo! Finance]
Medium
Report
MetaVia to Present New Phase 1 and Pre-Clinical Data on DA-1726 at ObesityWeek® 2025 [Yahoo! Finance]
11/4
04:01 pm
mtva
MetaVia to Present New Phase 1 and Pre-Clinical Data on DA-1726 at ObesityWeek® 2025
High
Report
MetaVia to Present New Phase 1 and Pre-Clinical Data on DA-1726 at ObesityWeek® 2025
10/27
08:31 am
mtva
MetaVia Announces Poster Presentation on Vanoglipel (DA-1241) at the AASLD Liver Meeting
Low
Report
MetaVia Announces Poster Presentation on Vanoglipel (DA-1241) at the AASLD Liver Meeting
10/25
12:09 pm
mtva
MetaVia (NASDAQ:MTVA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
MetaVia (NASDAQ:MTVA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/20
08:31 am
mtva
MetaVia Announces Poster Presentations on DA-1726 at ObesityWeek® 2025
Low
Report
MetaVia Announces Poster Presentations on DA-1726 at ObesityWeek® 2025
10/14
08:31 am
mtva
MetaVia to Present at the H.C. Wainwright Liver Disease Virtual Conference
Medium
Report
MetaVia to Present at the H.C. Wainwright Liver Disease Virtual Conference